Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ebos GroupEBOSF +15.85%85 Shiller PE Ratio is 33.93 as of Jul. 30, 2026, which is 9% above its 10-year median of 31.25. GuruFocus rates EBOSF with a GF Score™ of 85/100 and a GF Value™ of $43.41. The stock has 4 warning signs investors should review. Among 66 Medical Distribution companies, Ebos Group ranks worse than 56.06% on this metric.
As of today (2026-07-30), Ebos Group's current share price is $23.75. Ebos Group's E10 for the fiscal year that ended in Jun25 was $0.70. Ebos Group's Shiller PE Ratio for today is 33.93.
The historical rank and industry rank for Ebos Group's Shiller PE Ratio or its related term are showing as below:
EBOSF'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.9 Med: 31.25 Max: 48.6
Current: 16.79
During the past 13 years, Ebos Group's highest Shiller PE Ratio was 48.60. The lowest was 14.90. And the median was 31.25.
EBOSF's Shiller PE Ratio is ranked worse than 56.06% of 66
companies
in the Medical Distribution industry
Industry Median: 14.525
vs EBOSF: 16.79
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Ebos Group's adjusted earnings per share data of for the fiscal year that ended in Jun25 was $0.708. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.70 for the trailing ten years ended in Jun25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Ebos Group (OTCPK:EBOSF) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Ebos Group Shiller PE Ratio Related Terms
Ebos Group Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for Ebos Group's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBOSF vs MCK, COR, CAH: Shiller PE Ratio Comparison
For the Medical Distribution subindustry, Ebos Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group Shiller PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Ebos Group's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Ebos Group's Shiller PE Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group's E10 for the fiscal year that ended in Jun25 is calculated as:
For example, Ebos Group's adjusted earnings per share data for the fiscal year that ended in Jun25 was:
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Ebos Group (EBOSF) has a Shiller PE Ratio of 33.93 as of Jul. 30, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Ebos Group and its competitors. This is near median its historical median of 31.25. Over the past decade, Ebos Group's Shiller PE Ratio has ranged from 14.90 to 48.60. According to the industry distribution chart, Ebos Group ranks #37 out of 66 companies in the Medical Distribution industry, placing it in the top 56.1%.
Is Ebos Group's Shiller PE Ratio too high?
Ebos Group's current Shiller PE Ratio of 33.93 is near median its 10-year median of 31.25. Over the past 10 years, this metric has ranged from a low of 14.90 to a high of 48.60. The Medical Distribution industry median Shiller PE Ratio is 14.53. Ebos Group's value of 33.93 is 133.6% above this industry median. Based on the distribution chart, Ebos Group ranks #37 out of 66 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Ebos Group has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Shiller PE Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #37 out of 66 companies for Shiller PE Ratio. This places Ebos Group in the lower half of its industry. The industry median Shiller PE Ratio is 14.53. Ebos Group's value of 33.93 is 133.6% above this benchmark. Historically, Ebos Group's own Shiller PE Ratio has ranged from 14.90 to 48.60 over the past decade. While the company's 10-year median is 31.25 vs. the industry median of 14.53, Ebos Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Medical Distribution company?
The median Shiller PE Ratio among Medical Distribution companies is 14.53, based on 66 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current Shiller PE Ratio of 33.93 is 133.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median Shiller PE Ratio is 14.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current Shiller PE Ratio is 33.93, which is near median its own 10-year median of 31.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Ebos Group (EBOSF) has a current Shiller PE Ratio of 33.93. The stock's GF Value™ is $43.41, compared to a current price of $23.75 — trading 45.3% below its estimated fair value. The current Shiller PE Ratio is 33.93, which is near median its 10-year median of 31.25 and 133.6% above the Medical Distribution industry median of 14.53. Ebos Group's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For Ebos Group (EBOSF), the current Shiller PE Ratio is 33.93 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (EBOSF) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of $23.75 is trading 45.3% below its estimated GF Value™ of $43.41.
Key valuation signals for EBOSF:
Shiller PE Ratio: 33.93 (near median its 10-year median of 31.25)
GF Value™: $43.41 vs. price of $23.75 (45.3% below fair value)
Industry Position: 133.6% above the Medical Distribution median (#37 of 66)
No single metric tells the full story. See the EBOSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
85GF Score
Get the complete analysis for EBOSF
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EBOSF has been successfully added to your 
